Verition Fund Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-18,425
| Closed | -$875K | – | 3479 |
|
|
2025
Q3 | $875K | Buy |
+18,425
| New | +$892K | 0.01% | 2627 |
|
|
2025
Q2 | – | Sell |
-18,417
| Closed | -$746K | – | 3613 |
|
|
2025
Q1 | $746K | Sell |
18,417
-15,018
| -45% | -$637K | ﹤0.01% | 2331 |
|
|
2024
Q4 | $930K | Buy |
+33,435
| New | +$1.01M | ﹤0.01% | 2099 |
|
|
2024
Q3 | – | Sell |
-9,256
| Closed | -$217K | – | 3155 |
|
|
2024
Q2 | $217K | Buy |
+9,256
| New | +$198K | ﹤0.01% | 2544 |
|
|
2023
Q2 | – | Sell |
-5,360
| Closed | -$205K | – | 2179 |
|
|
2023
Q1 | $205K | Buy |
+5,360
| New | +$239K | ﹤0.01% | 1751 |
|
